TKTL2 anticorps (C-Term)
Aperçu rapide pour TKTL2 anticorps (C-Term) (ABIN7465042)
Antigène
Voir toutes TKTL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the C-terminus region of human TKTL2. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: 293T
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- TKTL2 (Transketolase-Like 2 (TKTL2))
-
Autre désignation
- transketolase like 2
-
Sujet
- Transketolase like 2,Plays an essential role in total transketolase activity and cell proliferation in cancer cells, after transfection with anti-TKTL1 siRNA, total transketolase activity dramatically decreases and proliferation was significantly inhibited in cancer cells. Play a pivotal role in carcinogenesis.
-
Poids moléculaire
- 68 kDa
-
ID gène
- 84076
-
UniProt
- Q9H0I9
Antigène
-